Research PREVIEW for2015 Global Survey on Flow Cytometry Adoption Trends

Fluorescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer

Technologies

Research Objectives

The primary goal of this research is to analyze the utilization of flow cytometry

instruments and reagents. Key information the survey seeks to collect include the

following:

• Factors that drive the selection of flow cytometers

• Predominantly used applications for flow cytometers

• Respondents’ most preferred brands and why

• How laboratories feel about test volumes in 2015

• Why laboratories are utilizing these specific products and how likely they are to

continue using these products

• Which of the clinical applications use flow cytometer predominantly

• Other complementary technologies used along with flow cytometry

• Unmeet needs and challenges

• Cells that are of interest

• Laboratory budgets for new equipment/reagent purchasesSource: Frost & Sullivan

Research Methodology

Methodology

Laboratories were invited to participate in an online survey in March 2015. To qualify for survey participation, respondents must work within a laboratory, hospital, academic facility, or government facility that use flow cytometry. Respondents should be a constant user of flow cytometer, belong to the scientific community, and be in a position to authorize purchases and handle laboratory budgets.

Sample

The target group was screened to ensure only qualified respondents participated. In total, 112 decision makers qualified for the survey, representing the following types of laboratories:

• Private laboratories include biotechnology firms, blood banks, independent laboratories, and private institutes.

• Government funded laboratories include government aided organizations and government affiliated research institutes.

• Academic refers to academic core flow facilities, imaging facilities, university labs, academic labs, and research group labs.

• Hospital laboratories refer to those flow facilities that are within hospitals, cancer centers, medical centers, and medical schools.

Source: Frost & Sullivan

Research Methodology (continued)

Organization Type Sample Size

Private labs 22

Academic core facility and research labs 43

Hospitals 21

Government funded labs 20

Pharma and contract research organizations (CRO) 6

Total 112

Source: Frost & Sullivan

Reporting Notes• The base (N) is significant (greater than 30) for all industries except pharma and CRO.• Respondents indicated a wide range of job titles such as lab directors, scientists, lab

managers, fish biologists, medical technologists, PhDs, postdoctoral, and technicians. For convenience, the different titles are grouped into 3 major categories in this study: directors and department heads, lab managers, and research professionals.

• In total, about 71 percent of respondents work in the United States, and about 13 percent work in Europe. Nevertheless, this study is considered global because the survey was open to respondents from all countries.

• Monetary values are reported in US dollars.• Due to rounding, percentages in charts and tables may not sum to 100.

Respondent Demographics

Base: All respondents (n=112)Q1: In which country are you located?Q2: Which of the following best describes your organization? Q3: What is your job title?

Respondent’s Country: Global, 2015

North America: 70.5%

Europe: 12.5%

Africa: 0.9%

South Asia: 9.8%

Rest of World (ROW): 6.3%

Organization Type: Global, 2015

Acedmic laboratory or core facility: 38.4%

Private laboratory: 19.6%

Hospital: 18.8%

Governement funded laboratory: 17.9%

Pharma and CRO: 5.4%

Director and department head: 25.0%

Lab manager: 35.7%

Research professional: 39.3%

Main Laboratory Role: Global, 2015

Source: Frost & Sullivan

Key Highlights

Source: Frost & Sullivan analysis.

Influencing Factors

A greater number of respondents showed a preference towards fluorescence capabilities, detection sensitivity, and intended application, whereas factors such as optical alignment, throughput capabilities, and data analysis seemed to take less precedence.

Capital BudgetCore facilities that cater to hospitals have the maximum budget to purchase new equipment. About 47.4 percent of the cases reported a budget of $71,000 to $1,000,000.

Complementary Technology

Polymerase chain reaction (PCR) and microarray are the technologies that are predominantly used with flow cytometry. Next-generation sequencing is rapidly catching up, which could lead to possible partnerships for automated workflows between flow instrument vendors and sequencing vendors.

Brand PerceptionBD Biosciences, Beckman Coulter (Danaher), and EMD Millipore remain strong as preferred brands, respectively. In addition, respondents have a strong preference for Sony Biotechnology as a future preferred brand.

BD Biosciences

Beckman Coulter

Miltenyi Biotec

EMD Millipore Corporation

0

1

2 3

4

5Low High

0

1

2 3

4

5Low High

0

1

2 3

4

5Low High

0

1

2 3

4

5Low High

Current Use Future Preference

Sony Biotechnology Inc.

0

1

2 3

4

5Low High

0

1

2 3

4

5Low High

0

1

2 3

4

5Low High

0

1

2 3

4

5Low High

0

1

2 3

4

5Low High 0

1

2 3

4

5Low High

Participants

Source: Frost & Sullivan

Brand Perception

Key Takeaway: BD Biosciences, Beckman Coulter (Danaher), and EMD Millipore remain strong; however, there is a strong preference for Sony Biotechnology as a future preferred brand.

The Full Analysis Features the Following Content

Section Slide Number

Research Background, Objectives, Methodology, and Respondent Demographics 5

Executive Summary 10

Utilization of Flow Cytometry 16

• Flow Cytometer Utilization 17

• Utilization by Research versus Clinical versus Industrial 18

• Overall Number of Colors Used 19

• Overall Number of Colors Used by Organization Type 20

Brand Perception 21

• Overall Brand Awareness of Flow Cytometry 22

• Brands Used by Organization Type 23

• Brands Used by Application Type 24

• Specific Brands Favored for Research Applications 25

• Specific Brands Favored for Clinical Applications 26

Laboratory Budgets and Future Adoption Plans 27

• Overall Laboratory Budget 28

9

The Full Analysis Features the Following Content (continued…)

Section Slide Number

• Laboratory Budget by Organization Type 29

• Future Adoption by Organization Type 30

• Future Preferred Brands by Organization Type 31

Complementary Technologies to Flow Cytometry 32

• Ancillary Technologies to Flow Cytometry 33

• Ancillary Technologies to Flow Cytometry by Organization Type 34

Test Volume Analysis 35

• Perception on Sample Inflow 36

• Sample Volume—Academic Core Labs and Research Institutes 37

• Sample Volume—Government Affiliated Centers 38

• Sample Volume—Private Labs 39

• Sample Volume—Hospital Labs 40

Research versus Clinical Use 41

• Predominantly Used Research Applications 42

• Predominantly Used Research Applications by Organization Type 44

• Predominantly Used Clinical Applications 46

Section Slide Number

• Predominantly Used Clinical Applications—Academic 48

• Predominantly Used Clinical Applications—Private 49

• Predominantly Used Clinical Applications—Government 50

• Predominantly Used Clinical Applications—Hospitals 51

Key Influencing Factors 52

Open Ended—Voice of the Customer 56

• Unmet Needs by Organization Type—Verbatim Responses 57

• Cells of Interest—Verbatim Responses 59

• Conclusions 62

Appendix 64

The Frost & Sullivan Story 66

Please contact Frost & Sullivan for upcoming research services on the global flow cytometry market.

The Full Analysis Features the Following Content (continued…)

Interested in Full Access? Connect With Us

Kayla Belcher Corporate Communications – North America

210.247.2450

kayla.belcher@frost.com

Research Authors

Divyaa RavishankarSenior Industry

AnalystHealthcare

Greg CaressiVice President of

ResearchHealthcare

Facebookhttps://www.facebook.com/FrostandSullivan

LinkedIn Grouphttps://www.linkedin.com/company/frost-&-sullivan

SlideSharehttp://www.slideshare.net/FrostandSullivan

Twitterhttps://twitter.com/Frost_Sullivan

Frost & Sullivan Eventshttp://bit.ly/MvPRbQ

GIL Communityhttp://ww2.frost.com/gil-community/

Global Perspective40+ Offices Monitoring for Opportunities and Challenges

Industry ConvergenceComprehensive Industry Coverage Sparks Innovation Opportunities

Automotive&

Transportation

Aerospace & Defense Measurement &Instrumentation

Information &Communication Technologies

HealthcareEnvironment & BuildingTechnologies

Energy & PowerSystems

Chemicals, Materials& Food

Electronics &Security

Industrial Automation& Process Control

AutomotiveTransportation & Logistics

ConsumerTechnologies

Minerals & Mining